← Browse by Condition
Medical Condition
ewing sarcoma
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 1
NCT05734066 Phase 1, Phase 2
Recruiting
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Enrollment
60 pts
Location
United States, Canad...
Sponsor
Jazz Pharmaceuticals
NCT05062707
Recruiting
Early Ageing During Therapy in AYA Cancer Patients
Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
NCT06541262 Phase 1, Phase 2
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Enrollment
104 pts
Location
United States, Canad...
Sponsor
Milton S. Hershey Medical Cent...
NCT04337177 Phase 1
Recruiting
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Enrollment
20 pts
Location
United States
Sponsor
Valent Technologies, LLC
NCT06068075
Recruiting
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Enrollment
340 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06796543
Recruiting
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Enrollment
70 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...